We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current VCNX market cap is 7.06M. The company's latest EPS is USD -17.3585 and P/E is -0.35.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 50k | 225k | 550k | 0 | 20k |
| Operating Income | -4.79M | -5.12M | -4.99M | -7.08M | -5.83M |
| Net Income | -4.76M | -5.08M | -4.96M | -7.06M | -4.91M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 523k | 625k | 900k | 275k | 570k |
| Operating Income | -32.02M | -28.33M | -22.49M | -19.91M | -22.89M |
| Net Income | -31.86M | -28.85M | -22.38M | -19.82M | -20.25M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 8.61M | 7.98M | 4.9M | 3.09M | 2.56M |
| Total Liabilities | 2.29M | 2.78M | 2.5M | 3.51M | 6.43M |
| Total Equity | 6.32M | 5.19M | 2.4M | -423k | -3.87M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4.6M | 11.7M | 9.84M | 7.98M | 3.63M |
| Total Liabilities | 6.88M | 14.31M | 2.43M | 2.78M | 5.94M |
| Total Equity | -2.27M | -2.61M | 7.41M | 5.19M | -2.31M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -14.48M | -19.07M | -5.04M | -10.55M | -13.64M |
| Investing | -101k | -99k | -49k | -49k | -67k |
| Financing | 13.17M | 16.98M | 2.02M | 6.11M | 7.45M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -30.72M | -28.65M | -25.3M | -19.07M | -17.23M |
| Investing | 14.07M | -290k | -32k | -99k | -67k |
| Financing | 13.8M | 36.76M | 23.32M | 16.98M | 12.45M |
| Market Cap | 7.06M |
| Price to Earnings Ratio | -0.35 |
| Price to Sales Ratio | 12.38 |
| Price to Cash Ratio | 4.6 |
| Price to Book Ratio | -3.05 |
| Dividend Yield | - |
| Shares Outstanding | 1.17M |
| Average Volume (1 week) | 8.19k |
| Average Volume (1 Month) | 9.61k |
| 52 Week Change | -92.00% |
| 52 Week High | 100.80 |
| 52 Week Low | 4.432 |
| Spread (Intraday) | 1.6 (24.21%) |
| Company Name | Vaccinex Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.vaccinex.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
